Concepedia

Xu De Wang

XD

Statistics

Publications

4

Citations

88

H-Index

4

Active since

2016

Affiliations

Shenyang Pharmaceutical University(Current)

Xu De Wang is an author at Shenyang Pharmaceutical University specializing in cancer pharmacology, oncology, and cancer cell apoptosis.

Publications per year

2016–2020

4

Publications

4

Anticancer activity and potential mechanisms of 1C, a ginseng saponin derivative, on prostate cancer cells

Xu De Wang, Guang Yue Su, Chen Zhao et al. · Journal of Ginseng Research · 2017 · 38 citations · Full text

Medicine, Oncology, Pharmacology +10

12-Chloracetyl-PPD, a novel dammarane derivative, shows anti-cancer activity via delay the progression of cell cycle G2/M phase and reactive oxygen species-mediate cell apoptosis

Xu De Wang, Yuan Sun, Chen Zhao et al. · European Journal of Pharmacology · 2016 · 21 citations

Medicine, Oncology, Pharmacology +17

2-Pyrazine-PPD, a novel dammarane derivative, showed anticancer activity by reactive oxygen species-mediate apoptosis and endoplasmic reticulum stress in gastric cancer cells

Xu De Wang, Tao Li, Yan Li et al. · European Journal of Pharmacology · 2020 · 17 citations

Life Sciences, Oncology, Pharmacology +17

RETRACTED: 4-XL-PPD, a novel ginsenoside derivative, as potential therapeutic agents for gastric cancer shows anti-cancer activity via inducing cell apoptosis medicated generation of reactive oxygen species and inhibiting migratory and invasive

Xu De Wang, Yuan Sun, Fan Qu et al. · Biomedicine & Pharmacotherapy · 2019 · 12 citations · Full text

Medicine, Oncology, Pharmacology +13

1–4 of 4